In a session titled, Better meeting the needs of people living with HIV, health experts reminded us that science, care, and human rights must move together if we are to achieve real change.

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

The mystery of how cancers build up resistance mechanisms and evade the treatments that should have destroyed them is a ...

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...